Product Information
IBUPROFEN 200 MG TABLET is a generic product labeled by Cardinal Health, priced at $0.0320 per EA under NDC 70000017501. Its NADAC has been published 428 times since Apr 18, 2018.
Strength
200 mg/1
Manufacturer
Cardinal HealthNDC
70000017501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA072096On Market Since
11/30/2016
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 200 MG TABLET has been published 428 times since Apr 18, 2018, and over the history we have for it it has risen 17.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0320 per EA |
|---|---|
| All-time high | $0.0370 (Nov 12, 2025) |
| All-time low | $0.0270 (Jul 18, 2018) |
| 52-week high | $0.0370 |
| 52-week low | $0.0320 |
| Median price | $0.0332 |
| Average price | $0.0330 |
| Largest weekly change | -13.7% (Apr 17, 2024) |
| Weeks tracked | 428 |
| Tracking since | Apr 18, 2018 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IBUPROFEN 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 200 MG TABLET, manufactured by Cardinal Health, is $0.0320 per EA (NDC 70000017501), effective Jun 24, 2026.
How has the price of IBUPROFEN 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 200 MG TABLET has risen 17.1%. It has been tracked across 428 weekly CMS publications since Apr 18, 2018.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 200 MG TABLET?
Since Apr 18, 2018, the NADAC for IBUPROFEN 200 MG TABLET has ranged from a low of $0.0270 (Jul 18, 2018) to a high of $0.0370 (Nov 12, 2025), with a median of $0.0332 per EA.
Are there cheaper alternatives to IBUPROFEN 200 MG TABLET?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IBUPROFEN 200 MG TABLET, is $0.0269 per EA — about 16% below IBUPROFEN 200 MG TABLET.
Who manufactures IBUPROFEN 200 MG TABLET?
IBUPROFEN 200 MG TABLET (NDC 70000017501) is labeled by Cardinal Health, and CMS classifies it as a generic product.
Related Drugs
Same classification